Immunization Against Major Communicable Diseases

Introduction to Immunization and Primary Health Care

Immunization stands as one of the most cost-effective public health interventions globally, forming a cornerstone of Primary Health Care (PHC). At the community level in Nigeria, PHC centres serve as the frontline delivery points where vaccines reach mothers and infants. Preventing infectious diseases before they manifest reduces the burden on secondary and tertiary health facilities, keeping communities productive and lowering infant mortality rates.

Basic Immunology Concepts: Active and Passive Immunity

Immunity protects the human body against invading pathogens through distinct physiological mechanisms.

• Active Immunity: Acquired when the body's immune system responds to antigens by producing specific antibodies and memory cells. This provides long-lasting protection and occurs either naturally through infection or artificially via vaccination.
• Passive Immunity: Acquired by transferring ready-made antibodies from another source, such as maternal antibodies crossing the placenta to a foetus. This offers immediate but temporary protection, as the body does not create its own memory cells.

The National Programme on Immunization (NPI) Schedule in Nigeria

The National Programme on Immunization outlines the mandatory timeline for administering childhood vaccines in Nigeria to protect against endemic communicable diseases. Adhering to this schedule ensures infants build robust immunity during their most vulnerable developmental windows.

Missed doses should be caught up promptly using national catch-up guidelines without restarting the entire schedule.

Target Major Communicable Diseases and Vaccine-Preventable Illnesses

Routine immunization targets specific infectious diseases that historically caused high morbidity and mortality among children.

• Poliomyelitis: A viral infection attacking the nervous system, causing irreversible paralysis.
• Tuberculosis: A bacterial infection primarily affecting the lungs, preventable with the BCG vaccine.
• Measles: A highly contagious viral illness characterized by fever, rash, and severe respiratory complications.
• Pertussis: Also known as whooping cough, presenting with severe paroxysmal coughing spells, part of the pentavalent vaccine protection.
• Yellow Fever: A viral haemorrhagic fever transmitted by mosquitoes, preventable through a single dose given at nine months.

Vaccine Handling, Storage, and the Cold Chain System

The cold chain system is a temperature-controlled supply network ensuring vaccines maintain potency from the manufacturing plant to the point of administration. Exposing vaccines to extreme heat or freezing temperatures destroys their biological components permanently.

• Temperature Ranges: Most vaccines require storage between +2°C and +8°C. Oral polio and yellow fever vaccines can withstand freezing, but diluents and liquid pentavalent vaccines must never freeze.
• Cold Chain Equipment: Includes walk-in cold rooms, deep freezers, solar refrigerators, vaccine carriers, and cold boxes equipped with conditioned ice packs.
• VVM (Vaccine Vial Monitor): A label containing a colour circle that changes irreversibly when exposed to cumulative heat, indicating whether the vaccine remains safe to use.

Administration Techniques and Safety Protocols

Proper administration guarantees that vaccines enter the correct tissue layers to elicit an optimal immune response while minimizing local adverse effects. Nurses must verify the vaccine type, check expiration dates, and inspect the VVM before drawing up any dose.

• Intradermal (ID): Used exclusively for the BCG vaccine, typically injected at the insertion of the deltoid muscle, producing a distinct skin bleb.
• Subcutaneous (SC): Used for measles and yellow fever vaccines, administered at a 45-degree angle into the fatty tissue.
• Intramuscular (IM): Used for pentavalent, pneumococcal, and tetanus toxoid vaccines, injected at a 90-degree angle into the anterolateral thigh for infants or deltoid for older children.
• Oral: Used for polio and rotavirus drops, administered directly into the child's mouth without touching the mucous membranes.

Adverse Events Following Immunization (AEFI): Surveillance and Management

An Adverse Event Following Immunization (AEFI) is any untoward medical occurrence that happens after a person receives a vaccine, whether causally related or coincidental. Healthcare providers must monitor, investigate, and report these occurrences promptly to maintain public confidence.

• Common Minor AEFIs: Localized pain, mild fever, redness, and swelling at the injection site. These resolve spontaneously within a few days with simple reassurance and cold compresses.
• Severe AEFIs: Rare occurrences such as anaphylaxis, high persistent fever, or febrile seizures requiring immediate medical intervention and emergency treatment.
• Surveillance Reporting: Nurses must document every adverse event in the national AEFI reporting register and notify local health authorities for investigation.

Community Mobilization, Health Education, and Overcoming Vaccine Hesitancy

Community mobilization engages local leaders, religious figures, and mothers' groups to foster local ownership of immunization programs. Vaccine hesitancy—the delay in acceptance or refusal of vaccines despite availability—threatens herd immunity and triggers disease outbreaks.

• Addressing Misconceptions: Nurses must listen patiently to parental fears, provide clear scientific facts without condescension, and use culturally appropriate communication.
• Outreach Strategies: Utilizing community town criers, school-based health talks, and market-square advocacy to reach hard-to-access populations.
• Herd Immunity: Achieving high vaccine coverage rates protects vulnerable, unimmunized individuals within the community by breaking transmission chains.